Login to Your Account

Pharma: Other News To Note

Thursday, May 30, 2013
• Perrigo Co., of Allegan, Mich., filed an abbreviated new drug application with the FDA for a generic version of Axiron (testosterone) topical solution, originally developed by Acrux Ltd., of Melbourne, Australia, and Eli Lilly and Co., of Indianapolis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription